Catalent Shares Outstanding 2012-2018 | CTLT

Catalent shares outstanding history from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Catalent shares outstanding for the quarter ending September 30, 2018 were 0.142B, a 11.24% increase year-over-year.
  • Catalent 2018 shares outstanding were 0.133B, a 5.1% increase from 2017.
  • Catalent 2017 shares outstanding were 0.127B, a 0.69% increase from 2016.
  • Catalent 2016 shares outstanding were 0.126B, a 3.73% increase from 2015.
Catalent Annual Shares Outstanding
(Millions of Shares)
2018 133
2017 127
2016 126
2015 121
2014 76
2013 75
2012 75
2011 75
Catalent Quarterly Shares Outstanding
(Millions of Shares)
Q1 2018 142
Q4 2018 133
Q3 2018 135
Q2 2017 133
Q1 2017 128
Q4 2017 127
Q3 2017 127
Q2 2016 126
Q1 2016 126
Q4 2016 126
Q3 2016 126
Q2 2015 126
Q1 2015 126
Q4 2015 121
Q3 2015 126
Q2 2014 126
Q1 2014 106
Q4 2014 76
Q3 2014 76
Q2 2013 75
Q1 2013 76
Q4 2013 0
Q3 2013 0
Q4 2012 0
Q4 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.483B $2.463B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.375B 11.43
Zoetis (ZTS) United States $43.289B 29.64
Grifols (GRFS) Spain $14.701B 17.94
Tilray (TLRY) United States $9.945B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.637B 12.40
Neurocrine Biosciences (NBIX) United States $7.919B 1746.60
Ionis Pharmaceuticals (IONS) United States $7.377B 0.00
Nektar Therapeutics (NKTR) United States $6.579B 9.43
Impax Laboratories (AMRX) United States $5.589B 29.71
Sage Therapeutics (SAGE) United States $5.144B 0.00
United Therapeutics (UTHR) United States $5.079B 8.31
Loxo Oncology (LOXO) United States $4.598B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.943B 14.60
FibroGen (FGEN) United States $3.332B 0.00
USANA Health Sciences (USNA) United States $2.876B 24.48
Endo (ENDP) Ireland $2.795B 4.28
Xencor (XNCR) United States $2.152B 0.00
TESARO (TSRO) United States $2.027B 0.00
Aerie Pharmaceuticals (AERI) United States $1.980B 0.00
Endocyte (ECYT) United States $1.939B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.895B 256.00
Heron Therapeutics (HRTX) United States $1.876B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.855B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.843B 0.00
Zogenix (ZGNX) United States $1.690B 0.00
PTC Therapeutics (PTCT) United States $1.654B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.516B 18.55
Theravance Biopharma (TBPH) Cayman Islands $1.453B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.398B 0.00
Corcept Therapeutics (CORT) United States $1.396B 20.49
Portola Pharmaceuticals (PTLA) United States $1.285B 0.00
Esperion Therapeutics (ESPR) United States $1.264B 0.00
Tricida (TCDA) United States $1.234B 0.00
TherapeuticsMD (TXMD) United States $1.125B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.075B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.900B 0.00
ImmunoGen (IMGN) United States $0.826B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.720B 0.00
Radius Health (RDUS) United States $0.706B 0.00
Karyopharm Therapeutics (KPTI) United States $0.648B 0.00
Flexion Therapeutics (FLXN) United States $0.605B 0.00
Collegium Pharmaceutical (COLL) United States $0.565B 0.00
GlycoMimetics (GLYC) United States $0.498B 0.00
ChemoCentryx (CCXI) United States $0.477B 37.80
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.473B 0.00
Siga Technologies (SIGA) United States $0.453B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.445B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 25.06
Dova Pharmaceuticals (DOVA) United States $0.423B 0.00
Odonate Therapeutics (ODT) United States $0.421B 0.00
Xeris Pharmaceuticals (XERS) United States $0.418B 0.00
Akebia Therapeutics (AKBA) United States $0.416B 0.00
Dermira (DERM) United States $0.409B 0.00
OptiNose (OPTN) United States $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.408B 0.00
ArQule (ARQL) United States $0.402B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.395B 0.00
Forty Seven (FTSV) United States $0.395B 0.00
Aclaris Therapeutics (ACRS) United States $0.359B 0.00
CASI Pharmaceuticals (CASI) United States $0.357B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Depomed (ASRT) United States $0.345B 12.83
Zafgen (ZFGN) United States $0.344B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.341B 0.00
KalVista Pharmaceuticals (KALV) United States $0.338B 0.00
Minerva Neurosciences (NERV) United States $0.324B 0.00
Aratana Therapeutics (PETX) United States $0.316B 0.00
Mast Therapeutics (SVRA) United States $0.315B 0.00
Translate Bio (TBIO) United States $0.309B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.303B 0.00
Tapimmune (MRKR) United States $0.301B 0.00
Affimed (AFMD) Germany $0.274B 0.00
Majesco Entertainment (PTE) United States $0.267B 0.00
IMV INC (IMV) Canada $0.248B 0.00
Lannett Co Inc (LCI) United States $0.241B 2.11
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Tyme Technologies (TYME) United States $0.227B 0.00
Opexa Therapeutics (ACER) United States $0.221B 0.00
Ocular Therapeutix (OCUL) United States $0.215B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.200B 0.00
MEI Pharma (MEIP) United States $0.194B 0.00
Calithera Biosciences (CALA) United States $0.189B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.189B 0.00
ElectroCore (ECOR) United States $0.182B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.181B 0.00
Neon Therapeutics (NTGN) United States $0.178B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.178B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.177B 0.00
Ardelyx (ARDX) United States $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 0.00
Molecular Templates (MTEM) United States $0.169B 0.00
ContraFect (CFRX) United States $0.160B 0.00
Redhill Biopharma (RDHL) Israel $0.160B 0.00
MediWound (MDWD) Israel $0.157B 0.00
Jounce Therapeutics (JNCE) United States $0.150B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.148B 0.00
Melinta Therapeutics (MLNT) United States $0.146B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
DURECT (DRRX) United States $0.138B 0.00
Adherex Technologies (FENC) United States $0.132B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.118B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.114B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.109B 0.00
Rafael Holdings (RFL) United States $0.108B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.099B 0.00
CTI BioPharma (CTIC) United States $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.093B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.089B 0.00
Achaogen (AKAO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Infinity Pharmaceuticals (INFI) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.075B 0.00
Natural Alternatives (NAII) United States $0.074B 7.25
Otonomy (OTIC) United States $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.070B 0.00
BioLineRx (BLRX) Israel $0.068B 0.00
KemPharm (KMPH) United States $0.068B 0.00
Immune Design (IMDZ) United States $0.065B 0.00
Forward Pharma (FWP) Denmark $0.062B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.061B 0.00
Novan (NOVN) United States $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 35.79
Neos Therapeutics (NEOS) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
Heat Biologics (HTBX) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.040B 0.00
Trillium Therapeutics (TRIL) Canada $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.036B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.87
Lipocine (LPCN) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
ESSA Pharma (EPIX) Canada $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.35
Shineco (TYHT) China $0.016B 1.61
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Skyline Medical (AIPT) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
PharmAthene (ALT) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00